Back to Search
Start Over
Epizyme Announces Expanded Loan Facility with Pharmakon Advisors for Additional $150 Million to Fund its Growth Initiatives
- Source :
- Legal Monitor Worldwide. November 9, 2020
- Publication Year :
- 2020
-
Abstract
- Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that the company has entered into an amended and restated agreement with funds [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Legal Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.640975346